Estimation of SARS-CoV-2 infection fatality rate by real-time antibody screening of blood donors

Viral Infections, Non-HIV

Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study

Lancet Infect Dis.

To KK, Tsang OT, Leung WS, Tam AR, Wu TC, Lung DC, Yip CC, Cai JP, Chan JM, Chik TS, Lau DP, Choi CY, Chen LL, Chan WM, Chan KH, Ip JD, Ng AC, Poon RW, Luo CT, Cheng VC, Chan JF, Hung IF, Chen Z, Chen H, Yuen KY

doi: 10.1016/S1473-3099(20)30196-1.

Viral Infections, Non-HIV

Antibody tests for identification of current and past infection with SARS-CoV-2

Cochrane Database Syst Rev.

Deeks JJ, Dinnes J, Takwoingi Y, Davenport C, Spijker R, Taylor-Phillips S, Adriano A, Beese S, Dretzke J, Ferrante di Ruffano L, Harris IM, Price MJ, Dittrich S, Emperador D, Hooft L, Leeflang MM, Van den Bruel A, Cochrane COVID-19 Diagnostic Test Accuracy Group.

doi: 10.1002/14651858.CD013652.

Viral Infections, Non-HIV

SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN)

Lancet

Hall VJ, Foulkes S, Charlett A, Atti A, Monk EJ, Simmons R, Wellington E, Cole MJ, Saei A, Oguti B, Munro K, Wallace S, Kirwan PD, Shrotri M, Vusirikala A, Rokadiya S, Kall M, Zambon M, Ramsay M, Brooks T, Brown CS, Chand MA, Hopkins S, SIREN Study Group.

doi: 10.1016/S0140-6736(21)00675-9

Viral Infections, Non-HIV

Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019

Clin Infect Dis.

Zhao J, Yuan Q, Wang H, Liu W, Liao X, Su Y, Wang X, Yuan J, Li T, Li J, Qian S, Hong C, Wang F, Liu Y, Wang Z, He Q, Li Z, He B, Zhang T, Fu Y, Ge S, Liu L, Zhang J, Xia N, Zhang Z

doi: 10.1093/cid/ciaa344.

Viral Infections, Non-HIV

Serological immunochromatographic approach in diagnosis with SARS-CoV-2 infected COVID-19 patients

J Infect.

Pan Y, Li X, Yang G, Fan J, Tang Y, Zhao J, Long X, Guo S, Zhao Z, Liu Y, Hu H, Xue H, Li Y

doi: 10.1016/j.jinf.2020.03.051.

Viral Infections, Non-HIV

Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study

Lancet.

Stringhini S, Wisniak A, Piumatti G, Azman AS, Lauer SA, Baysson H, De Ridder D, Petrovic D, Schrempft S, Marcus K, Yerly S, Arm Vernez I, Keiser O, Hurst S, Posfay-Barbe KM, Trono D, Pittet D, Gétaz L, Chappuis F, Eckerle I, Vuilleumier N, Meyer B, Flahault A, Kaiser L, Guessous I

doi: 10.1016/S0140-6736(20)31304-0.

Viral Infections, Non-HIV

SARS-CoV-2 seroprevalence, and IgG concentration and pseudovirus neutralising antibody titres after infection, compared by HIV status: a matched case-control observational study

Lancet HIV

Spinelli MA, Lynch KL, Yun C, Glidden DV, Peluso MJ, Henrich TJ, Gandhi M, Brown LB

doi: 10.1016/S2352-3018(21)00072-2

Viral Infections, Non-HIV

Human neutralizing antibodies elicited by SARS-CoV-2 infection

Nature.

Ju B, Zhang Q, Ge J, Wang R, Sun J, Ge X, Yu J, Shan S, Zhou B, Song S, Tang X, Yu J, Lan J, Yuan J, Wang H, Zhao J, Zhang S, Wang Y, Shi X, Liu L, Zhao J, Wang X, Zhang Z, Zhang L

doi: 10.1038/s41586-020-2380-z.

Viral Infections, Non-HIV

Persistence of anti-sars-cov-2 antibodies: immunoassay heterogeneity and implications for serosurveillance

Clin Microbiol Infect

Perez-Saez J, Zaballa ME, Yerly S, Andrey DO, Meyer B, Eckerle I, Balavoine JF, Chappuis F, Pittet D, Trono D, Kherad O, Vuilleumier N, Kaiser L, Guessous I, Stringhini S, Azman AS, Specchio-COVID19 Study Group.

doi: 10.1016/j.cmi.2021.06.040

Related content

Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study

Antibody tests for identification of current and past infection with SARS-CoV-2

SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN)

Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019

Serological immunochromatographic approach in diagnosis with SARS-CoV-2 infected COVID-19 patients

Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study

SARS-CoV-2 seroprevalence, and IgG concentration and pseudovirus neutralising antibody titres after infection, compared by HIV status: a matched case-control observational study

Human neutralizing antibodies elicited by SARS-CoV-2 infection

Persistence of anti-sars-cov-2 antibodies: immunoassay heterogeneity and implications for serosurveillance